PD-1/PD-L1 Are Novel Therapeutic Targets for Mastocytosis

被引：0
|
作者：
Geeze, Mary
Hatch, Ellen
Martin, Cheyenne
Perkins, Sherrie L.
Hartmann, Karin
Valent, Peter
Gotlib, Jason
Lidke, Diane
George, Tracy I.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Med Univ Lubeck, D-23538 Lubeck, Germany
[4] Med Univ Vienna, Vienna, Austria
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1371
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [1] PD-1/PD-L1 Are Novel Therapeutic Targets for Mastocytosis
    Geeze, Mary
    Hatch, Ellen
    Martin, Cheyenne
    Perkins, Sherrie L.
    Hartmann, Karin
    Valent, Peter
    Gotlib, Jason
    Lidke, Diane
    George, Tracy I.
    LABORATORY INVESTIGATION, 2016, 96 : 346A - 346A
  • [2] PD-L1 and PD-1 Expression Patterns in Systemic Mastocytosis
    Wang, Hao-Wei
    Sharma, Sachein
    Hahn, Jamie
    Komarow, Hirsh
    Eisch, Robin
    Metcalfe, Dean D.
    Maric, Irina
    MODERN PATHOLOGY, 2017, 30 : 383A - 383A
  • [3] PD-L1 and PD-1 Expression Patterns in Systemic Mastocytosis
    Wang, Hao-Wei
    Sharma, Sachein
    Hahn, Jamie
    Komarow, Hirsh
    Eisch, Robin
    Metcalfe, Dean D.
    Maric, Irina
    LABORATORY INVESTIGATION, 2017, 97 : 383A - 383A
  • [4] Novel PD-1 blockade bioassay to assess therapeutic antibodies in PD-1 and PD-L1 immunotherapy programs
    Cheng, Zhi-Jie Jey
    Karassina, Natasha
    Grailer, Jamison
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    CANCER RESEARCH, 2015, 75
  • [5] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [6] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [8] Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
    De Almeida, Steven
    Regimbeau, Mathilde
    Jego, Gaetan
    Garrido, Carmen
    Girodon, Francois
    Hermetet, Francois
    CANCERS, 2020, 12 (09) : 1 - 21
  • [9] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [10] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
12345